Thursday, 7 April 2016

Genetic Testing Perspective in the Global Scenario

Genetic testing is the most sophisticated techniques used to test for genetic disorders. It involves direct assessment of the DNA molecule. Genetic testing, which recently has been transforming itself from service to product driven market is expected to provide momentum to diagnostic companies with respect to development of their procedures. The market is expected to increase for screening the newborns, diagnosing rare and fatal disorders, and predicting the chances of incidence of diseases, such as Huntington. Genetic tests for newborn screening are likely to increase hugely over the upcoming years. In addition, with go forward in genetic testing procedures, tests would be paying attention on early finding of Alzheimer disease, hemochromatosis, breast cancer, colorectal cancer, diabetes in young citizens, and rare forms of amyotrophic side sclerosis.

Genetic testing discovers finest cancer treatment for specific patients. Advancements in genetic testing, together with hereditarily engineered drugs, are likely to aid in tailoring personalized medication for specific races, persons, and families. Genetic counseling services are on the rise, specifically in the US. Presently, there are around 2,780 certified genetic counselors operating in United States. Direct-to-Consumer genetic testing is expected to open new avenues, for companies looking for areas to further develops their range of screening tests. The United States and Europe together account for about 83% of the global genetic testing market.

Predictive Breast Cancer Gene Testing Market
Predictive gene testing is utilized to detect disease or disorder inherited by examines gene mutations coupled with particular hereditary disease. Predictive gene testing is also known as presymptomatic testing due to the fact that this test is executed even before the early signs of the disease or disorder are observed and thus enable determining person’s risk of difficulty disease or disorder. Predictive breast cancer gene testing is presented to discover risk of breast cancer in an individual having a family history of breast cancer. 

Early discovery of breast cancer make possible for the absolute cure of the patient and saving pretentious breast of the patient. In view of the benefit of early finding of breast cancer, Government have in progress taking plans to stretch alertness about breast cancer and the early detection techniques available in their respective region. Increasing breast cancer rates worldwide is another major cause of concern for governments worldwide to spotlight on vigilance programs to decrease the morbidity rate breast cancer.

Factors such as growing incidences of breast cancer worldwide, Government are paying attention on dipping the morbidity rate of breast cancer and spreading responsiveness about the available treatments in respective countries are driving the predictive breast genetic testing market .  However, expiration of Myriad Genetics’s patent, BRCAnalysis gene test in coming years will allow the entry of many market players in this field.

No comments:

Post a Comment